TEVA PHARMACEUTICAL INDUSTRIES SPON ADR EACH REP 1 ORD SHS financial statements, including revenue, expenses, profit, and loss

The total revenue of 0LER for the last quarter is 3.83 B USD, and it's 14.45% lower compared to the previous quarter. The net income of Q1 24 is -139.00 M USD.